InxMed Announces Dosing of First Patient in a Phase Ib Trial of IN10018 as Monotherapy and Combination Therapy in Patients with Uveal Melanoma and NRAS mutant Metastatic Melanoma in the United States Mar 17, 2020 Life Science
Healthcare Roundup – BioELife expands COVID-19 prevention product line, CytoDyn advancing mid-stage study of PRO 140 for COVID-19 Mar 17, 2020 Life Science
Sanofi and Regeneron begin global Kevzara® (sarilumab) clinical trial program in patients with severe COVID-19 Mar 16, 2020 Life Science
Healthcare Roundup – President Trump declares national emergency over coronavirus, Gilead up 6% premarket on encouraging action of remdesivir in COVID-19 Mar 13, 2020 Life Science
Healthcare Roundup –Predictive Oncology up 50%，Neogen ramps up production of disinfectants to fight COVID-19 Mar 13, 2020 Life Science
Harbour BioMed Secures $85 Million in Financing Round to Support Clinical-Stage Compounds Mar 12, 2020 Life Science
U.S. Food and Drug Administration Approves Opdivo® (nivolumab) + Yervoy® (ipilimumab) for Patients with Hepatocellular Carcinoma (HCC) Previously Treated with Sorafenib Mar 12, 2020 Life Science
INOVIO Receives New $5 Million Grant to Accelerate Scale Up of Smart Delivery Device for Its COVID-19 Vaccine Mar 12, 2020 Life Science
Healthcare Roundup –Vir Biotech up 14% premarket on NIH coronavirus collaboration, RedHill Biopharma up 5% premarket on coronavirus plan Mar 11, 2020 Life Science
Japan’s Regulatory Agency, PMDA, Clears RepliCel Life Sciences to Proceed to Final Consultation for Tendon and Skin Cell Therapy Products Mar 11, 2020 Life Science
Healthcare Roundup – GT Biopharma up 20% on plan for coronavirus treatment, Novavax up 17% premarket on advancement of coronavirus vaccine Mar 10, 2020 Life Science
Japan’s Patent Office Issues RepliCel Two New Patents for its Regenerative Medicine Technologies Mar 10, 2020 Life Science
